Navigation Links
Global Cardio Care Celebrates EECP Patient’s 100th Birthday
Date:7/23/2014

Los Angeles, CA (PRWEB) July 23, 2014

Global Cardio Care, Inc., a management company for physician practices delivering Enhanced External Counterpulsation (EECP), is celebrating the 100th birthday of Albert Weber, a patient who receives EECP therapy at the health center.

Weber has been plagued with angina pectoris and ischemic heart disease. Since receiving ongoing EECP therapy since 1999, he no longer suffers from either diagnosis.

When Sara Soulati, CEO of Global Cardio Care, introduced the Sara Soulati Health For Life Program to complement EECP therapy, Weber was one of the first to adopt the lifestyle program to fight heart disease.

The Sara Soulati Health For Life Program is a vegan, plant-based nutrition and exercise program consisting of 35 hours of audiotapes to educate patients about lifestyle modification to fight and prevent cardiovascular disease. Soulati developed the preventive program after seeing the deficiency in patient education to help prevent and reverse cardiovascular disease.

In 1996 Soulati launched her career as a practitioner and pioneer of EECP therapy and in preventive lifestyle modification. She has a strong network of people who seek her expertise in both areas. Soulati has been working with physician practices since 1996 in Southern California, and Albert Weber has followed her from center to center to receive EECP therapy and Soulati's lifestyle modification program.

"Albert Weber is one of the dearest people I know, and he is part of my family. On his 100th birthday, he came for his EECP treatment and to celebrate his momentous day with me," said Sara Soulati, CEO of Global Cardio Care, Inc. "He shared with me 'I am so grateful to have received this treatment all these years, and I truly believe in my heart that EECP is the reason I have lived to this age with such great quality of life. EECP is just common sense because it's all about circulation. It's not about living a long life, it's what you do with your life that matters.'

Albert told me my program taught him to eat right and have positive thoughts that gave him hope. It was truly an honor to have celebrated Albert's centennial birthday with him."

About Sara Soulati and Global Cardio Care, Inc.

Sara Soulati is CEO of Global Cardio Care, Inc., a company she founded in 2002 in Los Angeles to manage physician practices dedicated to EECP therapy.

Soulati believes in empowering people because cardiovascular disease is a preventable and reversible disease. Her message is clear that coronary artery disease does not need to exist and if it does, it does not need to progress. Soulati's vegan, plant-based lifestyle program, the Sara Soulati Health For Life Program, is one of her primary tools to arm people with against cardiovascular disease. Soulati's goal is to one day abolish heart disease, and she works tirelessly to that end daily.

Read the full story at http://www.prweb.com/releases/sara-soulati/health-for-life/prweb12041606.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Surge in R&D Investments to Drive the Global Biocompatible Materials Market, According to New Report by Global Industry Analysts, Inc.
2. Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc.
3. Increasing Focus on Packaging as a Marketing Tool Drives the Blister & Other High Visibility Packaging Market, According to New Report by Global Industry Analysts, Inc.
4. Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets
5. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020
6. Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com
7. Global Eyeglasses Adds New Products and Enhances Services
8. Global Molecular Diagnostics Market Expected to Reach USD 8.7 Billion through 2019: Transparency Market Research
9. Ronald S. Weaver, MD, Owner of Global Cardio Care Centers, Announces EECP Treatment Success for Cardiomyopathy Patient Who Needed Heart Transplant
10. Live-Attenuated Vaccines to Dominate Dengue Vaccine Market Through 2020, Says GlobalData in Its Report Published at MarketPublishers.com
11. Elsevier conference Global Food Security honored at 2014 UK Conference Award Ceremony
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: